金黄色葡萄球菌a-溶血素亚单位疫苗在小白鼠模型的免疫效力评价

中国生物工程杂志

2009, Vol. 29

Issue (11): 17-22

研究报告

金黄色葡萄球菌a-溶血素亚单位疫苗在小白鼠模型的免疫效力评价

张海燕^1,2,杨宏军^1**,王长法^1**,何洪彬¹,仲跻峰¹,杨少华¹,马卫明²

1.山东省农业科学院奶牛研究中心济南 250100
2.山东农业大学动物科技学院泰安 271018

Evaluation of the Immunity Effectiveness on the Engineered Subunit Vaccine of Staphylococcus aureus α-Hemolysin

ZHANG Hai-yan^1,2,YANG Hong-jun¹,WANG Chang-fa¹,HE Hong-bin¹,ZHONG Ji-feng¹,YANG Shao-hua¹,MA Wei-ming²

1.Cow Research Center ,Agricultural Science Academy of Shandong Province, Jinan 250100,China
2.College of Veterinary Medicine，Shandong Agricultural University, Taian 271018,China

全文: PDF(543 KB) HTML

摘要：

目的:以小白鼠为试验模型，检测金黄色葡萄球菌α溶血素基因工程蛋白单位疫苗的抗体效价水平和免疫保护力，初步评价此亚单位疫苗的免疫效力。方法:Bradfrod法对目的蛋白进行蛋白含量测定，Geoffroy法测定目的蛋白半数溶血效价和活性，建立ELISA方法测定抗体效价，并且通过攻毒得出疫苗免疫保护力。结果:纯化的目的蛋白在53kDa处显示单一条带，蛋白含量为0.1278mg/ml；溶血比活为8012.5HU/mg；所有试验小鼠在首免一周后采集的血清中都检测到了特异性抗体，而抗体效价开始时呈逐渐上升趋势，达最高值后随时间延长逐渐降低。结论:纯化的目的蛋白达到电泳级纯度，且依然保持良好的黏附活性，蛋白疫苗作用机体产生的抗体水平符合抗体消长规律。

关键词： 金黄色葡萄球菌a-溶血素; 基因工程亚单位疫苗; 免疫效力

Abstract:

Objective:α -Hemolysin of Staphylococcus aureus, which was expressed in E.coli BL21(DE3) with recombinant pET32a+-α-HL plasmid, was purified with gel filtration chromatography(GFC), and then the engineered subunit vaccine was developed. The immunity effectiveness of this vaccine was evaluated on mouse models.Method:The purified fusion protein was analyzed in SDS-PAGE, and subjected to the evaluation of its median hemolytic dose potency(HD50) was finally analyzed with rabbit erythrocyte. Protein concentration was determined by the method of Bradford. Antibody titers were evaluated on ELISA, and then challenged to gain the immunity protect index.Results:There is an expected protein band with molecular mass of 53kDa in SDS-PAGE, and the concentration is 0.1278mg/ml. The hemolysis activity is 8012.5 HU/mg. There are specific antibodies acquired in bloodserum from mice after vaccined and the antibody titers rising until it has arrive the max, then following down.Conclusion:The purified fusion protein has good fineness and hemolysis activity, the antibody titers initiated by the protein vaccine go with regulation and the immunoprotection is satisfied.

Key words: Staphylococcus aureus a-hemolysin Engineered subunit vaccine Immunity effectiveness

收稿日期: 2009-04-02 出版日期: 2009-12-07

ZTFLH:

Q939.91

基金资助:

山东省农科院高技术自主创新基金（2006YCX027,2007YCX01703）、山东省农科院重大成果培育基金（2006YCG012）资助项目

通讯作者: 杨宏军;王长法 E-mail: longfei1997@sina.com;wcf1967@yahoo.com.cn

	服务
	把本文推荐给朋友
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	张海燕
	杨宏军
	王长法
	何洪彬
	仲跻峰
	杨少华
	马卫明

引用本文:

张海燕杨宏军王长法何洪彬仲跻峰杨少华马卫明. 金黄色葡萄球菌a-溶血素亚单位疫苗在小白鼠模型的免疫效力评价[J]. 中国生物工程杂志, 2009, 29(11): 17-22.

ZHANG Hai-Yan, YANG Hong-Jun, WANG Chang-Fa, HE Hong-Ban, ZHONG Ji-Feng, YANG Shao-Hua, MA Wei-Meng. Evaluation of the Immunity Effectiveness on the Engineered Subunit Vaccine of Staphylococcus aureus α-Hemolysin. China Biotechnology, 2009, 29(11): 17-22.

链接本文:

https://manu60.magtech.com.cn/biotech/CN/ 或 https://manu60.magtech.com.cn/biotech/CN/Y2009/V29/I11/17

［1］	Dinges M M, Orwin P M, Schlievert P M. Exotoxins of Staphylococcus aureus. Clinical Microbiology Reviews, 2000, 13:16~34
［2］	林峰强，潘杭君，胡松华. 奶牛乳腺炎疫苗研究进展. 中国奶牛，2002，(1)：40~42 Lin F Q, Pan H J, Hu S H. China dairy cattle, 2002，(1)：40~42
［3］	史冬艳, 郝永清. 奶牛乳房炎金黄色葡萄球菌疫苗研究进展. 中国兽药杂志, 2007, 41(2): 46~49 Shi D Y, Hao Y Q. Chinese Journal of Veterinary Drug, 2007, 41(2): 46~49
［4］	李殷. 葡萄球菌疫苗研制的进展和挑战. 国外医学(免疫学分册)，2003，26（4）：179~183 Li Y. Foreign medical sciences, 2003，26（4）：179~183
［5］	Alarcon J B, Waine G W, McManus D P. DNA vaccines:technology and application as antiparasite and antimicrobial agents. Adv Parasitol, 1999, 42: 343~410
［6］	Bruccoleri R E, Dougherty T J, Davison D B, et al. Concordance analysis of microbial genomes. Nucleic Acids Res, 1998, 16: 4482~4486
［7］	Entenza J M, Moreillon P, Senn M M, et al. Role of σB in the Expression of Staphylococcus aureus Cell Wall Adhesins ClfA and FnbA and Contribution to Infectivity in a Rat Model of Experimental Endocatditis. Infection and Immunity, 2005, 73(2):990~998
［8］	Park H M, Yoo H S, OH T H, et al. Immunogenicity of AlphaToxin, Capsular Polysaccharide (CPS) and Recombinant FibronectinBinding Protein (rFnBP) of Staphylococcus aureus in Rabbit. J Vet Med Sci,1999, 61(9): 995~1000
［9］	张延龄, 张晖. 疫苗学.北京：科学出版社, 2004.368~371, 437~446 Zhang Y L, Zhang H. Vaccinology. Beijing: Science Press, 2004. 368~371, 437~446
［10］	张善瑞, 赵宏坤, 杨宏军, 等. 金黄色葡萄球菌α溶血素的原核表达及其生物活性分析. 农业生物技术学报, 2007, 15(4): 727~728 Zhang S R, Zhao H K, Yang H J, et al. Journal of Agricultural Biotechnolog, 2007, 15(4): 727~728
［11］	方绍庆, 陆承平. 猪链球菌2型江苏分离株溶血素的纯化. 中国预防兽医学报, 2003, 25(5): 363~365 Fang S Q, Lu C P. Chinese Journal of Preventive Veterinary Medicine, 2003, 25(5): 363~365
［12］	陈国强, 陆承平, 姚火春. 猪链球菌2型溶血素的提纯及其生物学特性. 中国人兽共患病杂志, 2001, 17(5): 75~77 Chen G Q, Lu C P, Yao H C. Chinese Journal of Zoonoses, 2001, 17(5): 75~77
［13］	尚佑军，郁杰，李宏胜, 等. 乳牛乳腺炎多联苗免疫母鼠的乳腺抗感染试验研究. 中国兽医科技，2001，31（11）：30~31 Shang Y J, Yu J, Li H S, et al. Veterinary Science and Technology of China, 2001, 31(11):30~31
［14］	Leitner G, Lubashevsky E, Trainin Z. Staphylococcus aureus vaccine against mastitis in dairy cows, composition and evaluation of its immunogenicity in a mouse model. Veterinary Immunology and Immunopathology, 2003, 93(3~4): 159~167
［15］	吴一凡, 张双全, 高秀玉, 等. 乳糖诱导pET载体表达重组蛋白的研究. 南京师大学报(自然科学版), 2002, 25(1): 89~93 Wu Y F, Zhang S Q, Gao X Y, et al. Journal of NanJing Normal University（Natural Science Edition）, 2002, 25(1): 89~93
［16］	Bradford M M. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem, 1976, 72: 248~254
［17］	Geoffroy C, Gaillard J L, Alouf J E, et al. Purification, characterization, and toxicity of the sulfhydrylactived hemolysin listeriolysin O from Listeria monocytogenes. Infection and Immunity, 1987, 55(7): 1641~1646
［18］	Surujballi O P, Fackrell H B. Enzymelinked Immunosorbent Assay for Detection of Staphylococcus aureus AlphaToxin. Journal of clinical microbiology, 1984, 19(3): 394~398
［19］	Zhou H, Xiong Z Y, Li H P. An Iimmunogenicity Study of a Newly Fusion Protein Cna2FnBP Vaccinated against Staphylococcus aureus Infections in a Mice Model. Vaccine, 2006, 24 (22): 4830~4837
［20］	朱立平, 陈学清. 免疫学常用实验方法. 北京：人民军医出版社, 2000. 66~68 Zhu L P, Chen X Q. Experimental Methods Commonly Used in Immunology. Beijing: Medic of the People Press, 2000. 66~68
［21］	曹丙蕾. 奶牛乳腺炎三联灭活苗的研制及其免疫效力评价. 泰安: 山东农业大学, 动物科技学院，2007 Cao B L. Development on the triple inactived vaccine of the dairy cattle mastitis and the evaluation of the immunity effectiveness. Taian: Shandong Agricultural University, Institute of Aninmal Science and Technology, 2007
［22］	Leitner G., Yadlin N, Lubashevsky E, et al. Development of a Staphylococcus aureus vaccine against mastitis in dairy cows: Ⅱ Field trial. Veterinary Immunology and Immunopathology, 2003, 93 (3~4): 153~158
［23］	Leitner G., Lubashevsky E, Glickman A, et al. Development of a Staphylococcus aureus vaccine against mastitis in dairy cows:ⅠChallenge trials. Veterinary Immunology and Immunopathology, 2003, 93 (1~2): 31~38
［24］	Bhakdi S, TranumJensen J. Alphatoxin of Staphylococcus aureus. Microbiologyical Reviews, 1991, 55(4): 733~751
［25］	Herbelin C, Poutrel B, Rainard P, et al. Immune Recruitment and Bactericidal Activity of Neutrophils in Milk of Cows Vaccinated with Staphylococcus alphatoxin. Dairy Science, 1997, 80(9): 2025~2034
［26］	Jabocs A A, Loeffen P L, van den Berg A J. Identification,Purification,and Characterization of a thiolActivated Haemolysin (Suilyaion) of Streptcoccus suis. Infection and Immunity, 1994, 62(5): 1742~1748
［27］	Gottschalk M G, Lacouture S, Dubreuil J D. Characterization of Streptococus suis capsular type 2 hamelysin. Microbiology, 1995, 141(1):189~195

[1]	张继文杨桂连王春凤. 逆转录病毒载体在基因工程疫苗方面的应用[J]. 中国生物工程杂志, 2010, 30(06): 130-133.
[2]	郑其升徐公豹侯红岩张雪花侯继波. 以结核杆菌hsp70为载体的“通用型”禽流感疫苗构建及免疫效力研究[J]. 中国生物工程杂志, 2009, 29(12): 24-29.
[3]	汪恩浩. 酵母生产的HBsAg的化学结构及其免疫原性[J]. 中国生物工程杂志, 1995, 15(2): 43-45.

Viewed

Full text

Abstract

Cited

Shared

Discussed